Anna Angelaki
Datis Kalali
ID
 Email src
Chara Chantzara
Lanya Faiq
Maram Gad
Sabina Kadłubek
Jakub Kamiński
Zoi Charalampidi
Charalampos Charalampidis
Doxakis Anestakis
School of Medicine and Dentistry, European University of Cyprus, Nicosia, Cyprus
Medical School, University of Cyprus, Nicosia, Cyprus
School of Medicine and Dentistry, European University of Cyprus, Nicosia, Cyprus
School of Medicine and Dentistry, European University of Cyprus, Nicosia, Cyprus
School of Medicine and Dentistry, European University of Cyprus, Nicosia, Cyprus
Faculty of Medical Sciences, Medical University of Silesia, Katowice, Poland
Faculty of Medical Sciences, Medical University of Silesia, Katowice, Poland
School of Medicine and Dentistry, European University of Cyprus, Nicosia, Cyprus
Medical School, University of Cyprus, Nicosia, Cyprus
Medical School, University of Cyprus, Nicosia, Cyprus
Received: 18 December 2024 / Revised: 1 April 2025 / Accepted: 6 April 2025 / Published: 30 September 2025

Abstract

Introduction and aim. Cancers of the gastrointestinal tract are highly prevalent worldwide, with usually symptomless presentations making diagnosis at an early stage challenging. At the same time, salivary biomarkers are a promising method of early diagnosis in different malignancies. To this end, the present systematic review was carried out to investigate if salivary biomarkers can help with the early detection of gastrointestinal cancer and ascertain their diagnostic value.

Material and methods. Major electronic databases were searched using a combination of keywords and Boolean operators to retrieve all existing literature on the topic from April 2024 until inception. Clinical studies with relevant information were included in the quantitative synthesis.

Analysis of the literature. A total of 48 studies exploring the use of potential salivary biomarkers in esophageal, gastric, colorectal, pancreatic, hepatocellular and biomarkers were included in the present review. All studies retrieved statistically significant correlations between the presence of certain markers in the saliva and development of gastrointestinal cancers.

Conclusion. Salivary biomarkers can help detect different gastrointestinal cancers. However, more studies are required to determine their diagnostic value. The use of artificial intelligence might help clinicians in exploiting these biomarkers.

 

Cite

Angelaki A, Kalali D, Chantzara C, et al. Detection of gastrointestinal cancers using salivary biomarkers ‒ a systematic review. Eur J Clin Exp Med. 2025;23(3):750–766. doi: 10.15584/ejcem.2025.3.11.

 

This is an open access article distributed under the Creative Commons Attribution License which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited